SUBSCRIBE
SUBSCRIBE
News   Deals

Daiichi Sankyo Co Ltd. Says Offer for Ranbaxy Laboratories Oversubscribed

September 24, 2008 | 
1 min read
TOKYO, Sept 24 (Reuters) - Japan's third-largest drugmaker Daiichi Sankyo Co said on Wednesday its open offer to buy up to 20 percent of India's generic drugmaker Ranbaxy Laboratories Ltd was oversubscribed.
Mergers & acquisitions Asia
Daiichi Sankyo
MORE ON THIS TOPIC
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
July 16, 2025
 · 
1 min read
 · 
Tristan Manalac
AbbVie's office in South San Francisco, California
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
July 9, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Big fish with dollar sign eating many small ones. Competition, merger, business, monopoly concept. EPS 8 vector illustration, no transparency
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac